Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 103-110

  Banerjee, Antara ^a   Roychoudhury, Jayeeta ^a   Ali, Nahid ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Amastigotes; Drug; Membrane; Promastigotes

Indexed keywords

CATIONIC LIPOSOME; LIPOCORTIN 5; LIPOSOME; OCTADECYLAMINE; PHOSPHATIDIC ACID; PHOSPHATIDYLSERINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; DRUG MECHANISM; DRUG SELECTIVITY; ELECTRON MICROSCOPY; ERYTHROCYTE; FLUOROMETRY; LEISHMANIA; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROMASTIGOTE; SURFACE CHARGE;

ADENOSINE TRIPHOSPHATE; AMINES; ANIMALS; ANNEXIN A5; ANTIPROTOZOAL AGENTS; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; DRUG COMPOUNDING; ELECTROCHEMISTRY; LEISHMANIA DONOVANI; LIPOSOMES; MACROPHAGES, PERITONEAL; MEMBRANE POTENTIALS; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; OXYGEN CONSUMPTION; PHOSPHATIDYLSERINES; PROTEIN BINDING;

EID: 37549067732     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm396     Document Type: Article

References (32)

1. Murray HW, Berman JD, Davies CR et al. Advances in leishmaniasis. Lancet 2005; 366: 1561-77.
2. Golenser J, Domb A. New formulations and derivatives of amphotericin B for treatment of leishmaniasis. Mini Rev Med Chem 2006; 6: 1-10.
3. Olliaro PL, Guerin PJ, Gersti S et al. Treatment options for visceral leishmaniasis: A systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005; 5: 763-74.
4. Croft SL, Barrett MP, Urbina JA. Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005; 21: 508-12.
5. Neito J, Alvar J, Mullen AB et al. Pharmacokinetics, toxicities, and efficacies of sodium stibogluconate formulations after intravenous administration in animals. Antimicrob Agents Chemother 2003; 47 2781-7.
6. Papagiannaros A, Bories C, Demetzos C et al. Antileishmanial and trypanocidal activities of new miltefosine liposomal formulations. Biomed Pharmacother 2005; 59: 545-50.
7. Yoshihara E, Tachibana H, Nakae T. Trypanocidal activity of the stearylamine-bearing liposome in vitro. Life Sci 1987; 40: 2153-9.
8. Tachibana H, Yoshihara E, Kaneda Y et al. In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes. Antimicrob Agents Chemother 1988; 32: 966-70.
9. Afrin F, Dey T, Ali N. Leishmanicidal activity of stearylamine-bearing liposomes in vitro. J Parasitol 2001; 87: 188-93.
10. Tachibana H, Yoshihara E, Kaneda Y et al. Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes. J Parasitol 1990; 76: 352-5.
11. Dey T, Anam K, Afrin F et al. Antileishmanial activities of stearylamine-bearing liposomes. Antimicrob Agents Chemother 2000; 44: 1739-42.
12. Pal S, Ravindran R, Ali N. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice. Antimicrob Agents Chemother 2004; 48: 3591-3.
13. Afrin F, Ali N. Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect Immun 1997; 65: 2371-7.
14. Ephros M, Waldman E, Zilberstein D. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes. Antimicrob Agents Chemother 1997; 41: 1064-8.
15. Wanderley JLM, Moreira MEC, Benjamin A et al. Mimicry of apoptotic cells by exposing phosphatidylserine, participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts. J Immunol 2006; 176: 1834-9.
16. Kole L, Das L, Das PK. Synergistic effect of interferon-gamma and mannosylated liposome-incorporated doxorubicin in the therapy of experimental visceral leishmaniasis. J Infect Dis 1999; 180: 811-20.
17. Mangoni ML, Saugar JM, Dellisanti M et al. Temporins, small antimicrobial peptides with leishmanicidal activity. J Biol Chem 2005; 280: 984-90.
18. Borm HS, Bakalova R, Andra J. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. FEBS Lett 2005; 579: 6128-34.
19. Vieira L, Slotki I, Cabantchik ZI. Chloride conductive pathways which support electrogenic H+ pumping by Leishmania major promastigotes. J Biol Chem 1995; 270: 5299-304.
20. Dell Valle-Tascon S, Gimenez-Gallego G, Ramirez JM. Light-dependent ATP formation in a non-phototrophic mutant of Rhodospirillum rubrum deficient in oxygen photoreduction. Biochem Biophys Res Commun 1975; 66: 514-9.
21. Vercesi AE, Bernardes CF, Hoffmann ME et al. Digitonin permeabilization does not affect mitochondrial function and allows the determination of the mitochondrial membrane potential of Trypanosoma cruzi in situ. J Biol Chem 1991; 266: 14431-4.
22. Majumder S, Dey SN, Chowdhury R. Intracellular development of choleraphage phi 149 under permissive and nonpermissive conditions: An electron microscopic study. Intervirol 1988; 29: 27-38.
23. Tripathi A, Gupta CM. Transbilayer translocation of membrane phosphatidylserine and its role in macrophage invasion in Leishmania promastigotes. Mol Biochem Parasitol 2003; 128: 1-9.
24. Tiuman TS, Ueda-Nakamura T, Cortez DAG et al. Antileishmanial activity of Parthenolide, a Sesquiterpene Lactone isolated from Tanacetum parthenium. Andmicrob Agents Chemother 2005; 49: 176-82.
25. Diaz-Achirica P, Ubach J, Guinea A et al. The plasma membrane of Leishmania donovani promastigotes is the main target for CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide. Biochem J 1998; 330: 453-60.
26. Guerrero E, Saugar JM, Matsuzaki K et al. Role of positional hydrophobicity in the leishmanicidal activity of magainin 2. Antimicrob Agents Chemother 2004; 48: 2980-6
27. Glew RH, Saha AK, Das S et al. Biochemistry of the Leishmania Species. Microbiol Rev 1988; 52: 412-32.
28. Zachowski A. Phospholipids in animal eukaryotic membranes: Transverse asymmetry and movement. Biochem J 1993; 294: 1-14.
29. Stebelska K, Wyrozumska P, Sikorski AF. PS exposure increases the susceptibility of cells to fusion with DOTAP liposomes. Chem Biol Interact 2006; 160: 165-74.
30. Jacobs T, Bruhn H, Gaworski I. NK-lysin and its shortened analog NK-2 exhibit activities against Trypanosoma cruzi. Antimicrob Agents Chemother 2003; 47: 607-13.
31. Eda S, Sherman IS. Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cell Physiol Biochem 2002; 12: 373-84.
32. Utsugi T, Schroit AJ, Connor J et al. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 1991; 51: 3062-6.